Mahindra Group subsidiary, Mahindra Aerospace has been awarded a large aero-components production contract by Airbus Group company, Premium AEROTEC of Germany. The multi-year contract envisages the manufacture and supply by Mahindra of a variety of metallic components that will be fitted into several Airbus aircraft programs as part of assemblies produced by Premium AEROTEC.
Mahindra Aerospace’s deliverables under this contract will be in excess of a million parts per annum. The parts will be produced at the new Mahindra Aerostructures facility located at Narsapura, near Bengaluru, India. Deliveries to Premium AEROTEC’s facilities in Germany are scheduled to commence this year. Announcing the contract award during the 2015 Paris Air Show at Le Bourget, senior representatives of the Airbus and Mahindra groups mentioned that this contract is aligned with the Indian Government’s ‘Make in India’ initiative and validates the two Groups’ commitment to accelerate India’s participation in the global aerospace industry while simultaneously creating high-growth opportunities within India’s burgeoning aerospace and defense eco-system.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7551351-mahindra-airbus-make-in-india/
From transparent 3D televisions to bicycles you ride standing up, innovation was the name of the game at this year’s spring installment of the Canton Fair. Now, with the introduction of the new Canton Fair Design Awards (CF Awards), China’s most prestigious trade show is really driving cutting edge design to the next level. “Made in China” is about to become “Created in China
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
GAC Motor, China’s fastest-growing automaker, has wowed the Fortune Global Forum 2017 (“the Forum”) as the official service car provider with 380 cars including the GA8 sedan, the GS8 SUV and the GM8 MPV. The vehicles have provided safe and reliable service for leaders of the 152 Fortune 500 companies who attended, in addition to more than 1,100 distinguished guests from around the world. During the Forum, 40 CEOs from Fortune 500 companies including McKinsey & Company, Aisin Seiki (China) Investment Co., Ltd. and iFLYTEK Co., Ltd visited GAC Motor’s factory in Panyu, Guangzhou to get a glimpse of China’s advanced smart manufacturing capability.
“We are proud to have had the chance to display our advanced smart manufacturing capabilities to some of the world’s top corporate leaders,” said Yu Jun, president of GAC Motor. “Being chosen as the official service car provider for the Forum is a recognition of GAC Motor’s accomplishments in openness and innovation; it further enhances our brand’s international influence. After years of development, the Chinese automotive industry is now capable of creating top auto brands, and we hope to build GAC Motor into a world-class Chinese brand.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8241551-gac-motor-fortune-global-forum/
In its 25th year, Toyota’s annual Opportunity Exchange (OE) has resulted in more than $250 million in contracts for M/WBEs.
The two-day event – which included best-practice seminars, panel discussions and a trade show – concluded Tuesday, Oct. 28, at the Duke Energy Convention Center in downtown Cincinnati. Toyota Motor Engineering & Manufacturing North America (TEMA) started OE with about 100 attendees, and it has grown to become one of the largest minority business events in the country – attracting nearly 2,000 people who attend the event free of charge.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7353151-toyota-opportunity-exchange-minority-woman-owned-business-enterprises/
Data released today by the Association of Global Automakers (Global Automakers) demonstrates that their members’ presence in the U.S. continues to grow.
“With $46 billion invested into U.S. operations, our members are an integral part of the U.S. automobile industry,” said Michael J. Stanton, president and CEO of Global Automakers. “They are providing jobs for Americans and an essential part of the country’s manufacturing base.”
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62780-global-automakers-new-data-showcases-u-s-economic-impact
Things are humming along nicely here at EMO Hannover. The leading trade fair for the metalworking industry is home to the latest turning and grinding machines. But it’s not all metal on metal; there’s also a strong focus on sustainability, thanks to the German Engineering Federation’s “Blue Competence” initiative.
Today, the manufacturing industry made history, breaking the Guinness World Record for the “World’s Largest Coin Mosaic” during the International Manufacturing Technology Show (IMTS). In an effort to raise awareness of the vital role the manufacturing industry plays in the U.S. economy and the opportunities it presents for the next generation of workers, the mosaic incorporated more than $65,000 worth of coins – the amount of money manufacturing contributes to the U.S. economy each second.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7101156-sandvik-guinness-world-record-largest-coin-mosaic-international-manufacturing-technology-show-imts/
Call it a homecoming.
When Toyota introduced Lexus to the U.S. market in 1989, the Georgetown, Ky., plant – its first stand-alone vehicle manufacturing facility in America – was just in its second year of producing the Camry.
Fast forward 26 years and that same plant is celebrating the start of U.S. Lexus production. Today at a ceremony fit for a luxury brand king, the first-ever U.S.-produced ES 350 was unveiled before several thousand proud team members in Georgetown. And, just like a newborn foal at the nearby horse farms in Central Kentucky, the newcomer was brought into the world with plenty of TLC and hope for a bright future.
“This is really a proud moment for us and brings us full circle,” said Wil James, president, Toyota Motor Manufacturing, Kentucky, Inc. “To be the first wholly owned plant, building the number one best-selling car in America, the Camry, for 13 years in a row, and then to be selected to build the first Lexus is truly a tribute to our team members.”
For the past two and a half years, the Kentucky plant – Toyota’s largest in North America – has been gearing up to make the ES 350, Lexus’ best-selling sedan in the U.S. In all, $360 million was invested toward a new dedicated assembly line, adding 750 new jobs. Total capacity for the new line will be 50,000 vehicles.
To view the multimedia release go to:
http://www.multivu.com/players/English/7655351-lexus-kentucky-plant-es-350/
Combining their expertise in clinical trials support and cellular therapies, BloodCenter of Wisconsin (BCW) and the San Diego Blood Bank (SDBB) have created a strategic partnership to accelerate advancements in research and patient care. Together, BloodCenter of Wisconsin and San Diego Blood Bank will offer Celluvative™ – a portfolio of products and clinical trial services that will include esoteric laboratory testing, blood products for research and manufacturing applications, cell processing, and access to a broad database of diverse donors who have expressed interest in clinical trials.
“Through the strength of our partnership, we are able to offer end-to-end services to academic organizations, research institutions and other industry partners who are working to develop novel cellular therapy approaches,” said Matthew Anderson, M.D., Ph.D., medical director, BloodCenter of Wisconsin Diagnostic Laboratories. “Among other offerings, our Celluvative portfolio enables access to an extremely diverse donor database – an invaluable resource to enable advances in the area of regenerative medicine and drug discovery.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7855451-bloodcenter-sdbb-celluvative/
The U.S. Environmental Protection Agency (EPA) has proposed sweeping regulations that would require states to reduce carbon dioxide emissions from the electricity sector by an average of 30 percent nationally. This costly plan is another step in the administration's policies designed to eliminate low cost and reliable electricity and replace it with more expensive and less reliable sources.
"The rule is a stunning attempt to remake the nation's entire electric grid at great cost to households and businesses across the US. Our manufacturing base will become less competitive because of higher electricity prices. The impact of this regulation will be felt by families as they will spend more to heat and cool their homes. Those on fixed incomes and seniors will be forced to pay a disproportionately higher share of their monthly budget on utilities," said Hal Quinn, president and CEO, National Mining Association."
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7221731-national-mining-association-americans-electricity-bill-increase-due-to-epa-regulations/
ACG – the leading partner for pharmaceutical industry’s myriad requirements – is strengthening its product portfolio by launching several new machines at CPhI/P-MEC India, to be held during 2-4 December 2014, at Bombay Exhibition Centre, Mumbai.
P-MEC India, co-located with CPhI India, is one of the ‘must-attend’ events in the international pharmaceutical industry. With a booth that spreads over 1,000 sq. m., ACG will be displaying several new machines including the all-new ACG X.One Technology that reinvents the 12-bar safety features; Protab, a tablet press suited for small to medium batch sizes, and many more.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7391551-ACG-Launch-New-Machines-at-CPhI/
